Anzeige
Mehr »
Mittwoch, 06.08.2025 - Börsentäglich über 12.000 News
US-Kupfer-Geheimtipp legt nach: Strategisches Projekt zündet Phase 2 mit KI-Bohrplanung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Stuttgart
06.08.25 | 21:33
0,212 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2120,21622:47
0,2060,22222:00

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.07.Co-Diagnostics, Inc. - 8-K, Current Report1
29.05.Co-Diagnostics, Inc. - 8-K, Current Report1
08.05.Co-Diagnostics GAAP EPS of -$0.24 beats by $0.03, revenue of $0.05M misses by $0.14M7
08.05.Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
07.05.Co-Diagnostics Q1 2025 Earnings Preview2
CO-DIAGNOSTICS Aktie jetzt für 0€ handeln
07.05.Examining the Future: Co-Diagnostics' Earnings Outlook9
28.04.Co-Diagnostics, Inc. - 8-K, Current Report1
27.03.Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa10
27.03.Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results456SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the...
► Artikel lesen
27.03.Co-Diagnostics, Inc. - 10-K, Annual Report2
27.03.Co-Diagnostics, Inc. - 8-K, Current Report2
26.03.Uncovering Potential: Co-Diagnostics' Earnings Preview4
24.02.Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version6
21.02.Co-Diagnostics, Inc. - 8-K, Current Report-
21.02.Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance258The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/...
► Artikel lesen
07.11.24Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results240SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
08.08.24Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results323SALT LAKE CITY, August 8, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1